Intravenous Fluids in Benign Headaches Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

May 16, 2017

Primary Completion Date

May 15, 2019

Study Completion Date

May 15, 2019

Conditions
Headache
Interventions
DRUG

Normal Saline 5mL

Control arm subjects will receive Normal Saline 5 mL IV over 1 hour

DRUG

Normal Saline 20mL/kg

Study arm subjects will receive Normal Saline 20 mL/kg IV (up to 1000 mL) given IV over 1 hour,

DRUG

Prochlorperazine 0.15 mg/kg up to 10 mg IV

Standard Treatment Arm and Study Arm will receive prochlorperazine 0.15 mg/kg up to 10mg IV slow push

DRUG

Diphenhydramine 1 mg/kg up to 50 mg IV

Diphenhydramine dose 1 mg/kg up to 50 mg IV slow push

Trial Locations (1)

89102

University medical Center of Southern Nevada, Las Vegas

All Listed Sponsors
lead

University Medical Center of Southern Nevada

OTHER

NCT03185130 - Intravenous Fluids in Benign Headaches Trial | Biotech Hunter | Biotech Hunter